Cellectis ADR

CLLSNASDAQ · USD
1.09USD+0.03 (+2.36%)
622

Cellectis ADR (CLLS) Option Chain

Read more

Tracking the CLLS option chain helps you see every strike and expiry on Cellectis ADR in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CLLS options activity at a glance. Use our scanner to monitor the CLLS option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CLLS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where CLLS options are being actively traded, and where they are not.

Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316 for the treatment of Renal Cell Carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART22 to treat B-cell acute lymphoblastic leukemia.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
100.00102.800.00—2.802.50+135.85—3.401.411.99010.00
100.001500.750.00—0.755.00+371.703.804.403.910.190110.00
100.00002.600.00—2.607.50+607.554.608.406.410.09000.00

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank8.33% Low
  • Market cap (M$)77
  • 52 weeks high-80.55%
  • 52 weeks low20.45%
  • Analyst recommendationHold
    2.57
  • Target price$4.75
    360.83% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-13
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.65
  • EPS growth next 5 years-28.02%

As of Nov 17, 2026